Future of High-Density Lipoprotein Infusion Therapies

  • Bronwyn A. Kingwell
    From the Baker IDI Heart and Diabetes Institute, Melbourne, Australia (B.A.K.); and INSERM UMRS-939, Dyslipidemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France (M.J.C.).
  • M. John Chapman
    From the Baker IDI Heart and Diabetes Institute, Melbourne, Australia (B.A.K.); and INSERM UMRS-939, Dyslipidemia and Atherosclerosis Research Unit, Pitié-Salpetriere University Hospital, Paris, France (M.J.C.).

書誌事項

タイトル別名
  • Potential for Clinical Management of Vascular Disease

収録刊行物

  • Circulation

    Circulation 128 (10), 1112-1121, 2013-09-03

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ